The antimicrobial activity and possible synergistic effects of extracts and compounds isolated from Usnea steineri were evaluated against four resistant bacterial species. A phytochemical study of the acetone extract of U. steineri resulted in the isolation and characterization of difractaic acid and (+)-usnic acid as the main compounds. The acetone extract showed strong activity (less than 10 µg/mL) against resistant strains of Staphylococcus epidermidis and Enterococcus faecalis, and (+)-usnic acid exhibited strong activity against S. epidermidis (MIC 3.12 µg/mL), S. aureus and S. haemolyticus (MIC 12.5 µg/mL). Combinations of penicillin and tetracycline with (+)-usnic acid did not show any synergistic antimicrobial effects. Difractaic acid was inactive. Our results showed that the acetone extract of U. steineri possesses significant in vitro antimicrobial activity, which is likely related to the presence of (+)-usnic acid.
Over the past years, the increase in bacterial drug-resistance and the rapid emergence of new infections has decreased the efficiency of the drugs used to treat pathologies caused by certain microorganisms. The problem is in the way the drugs are used. The inappropriate overuse of antibiotics has resulted in a crisis situation due to the development of resistant strains by bacterial mutations [1] . According to the ECDC / EMEA [2] , it was estimated that in 2007, approximately 25,000 patients died from an infection caused by antibiotic-resistant bacteria in the European Union, Iceland and Norway. These infections resulted in approximately 2.5 million extra hospital days and extra in-hospital costs of more than EUR 900 million [2] .
There is an urgent need for the development of new antibacterial agents, preferentially from natural sources [3] .The plant kingdom represents a rich source of organic compounds, many of which have been in use as agents against several infectious and non-infectious diseases by the modern medicinal system. The World Health Organization estimated that approximately 80% of the population of developing countries relies on traditional medicines, mostly plant drugs, for their primary health care needs [4] . Similar to higher plants, lichens are considered potential sources of novel biologically active compounds and have been used in traditional medicine for years [5, 6] . Lichens are complex symbiotic associations between a fungus (mycobiont) and an alga or a cyanobacterium (photobiont) and are used for human nutrition, animal nutrition, for obtaining colors, perfumes and alcohol [7] .
In several European countries, many species of lichens have been used for the treatment of stomach diseases, pulmonary tuberculosis, whooping cough, diabetes, cancer and skin diseases [8] . Lichens and their metabolites exhibit several biological properties, such as antibiotic, antioxidant, anti-proliferative, anti-HIV, anti-cancer, anti-mycobacterial and anti-protozoan activities [9] [10] [11] .
The aim of this study was to evaluate the potential antimicrobial activity and synergistic effects of extracts and isolated compounds of the lichen Usnea steineri against resistant microorganisms.
In the HPLC chromatogram of the acetone extract of U. steineri, two major peaks were detected belonging to difractaic acid (1, Rt: 5.17 min) and (+)-usnic acid (2, Rt: 8.65 min). These two compounds were isolated and their identifications ratified by comparison of their 1 H and 13 C NMR spectroscopic and LC-MS data with literature values [12, 13] . This is the first record of difractaic acid in U. steineri.
The results for the antibacterial activity of the acetone extract and the major compounds against multidrug-resistant bacteria are displayed in Table 1 . -values greater than 400 µg/mL, Positive Control: vancomycin.
According to Rios and Recio [14] , experiments with quantities higher than 1 mg/mL for extracts or 0.1 mg/mL for isolated compounds should be avoided, but activity is interesting for concentrations below 100 μg/mL for extracts and 10 μg/mL for isolated compounds. (4) 2016 Tozatti et al.
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In this study the acetone extract showed strong activity (less than 10 μg/mL) against resistant strains of S. epidermidis and E. faecalis, with MIC values equal to 6.25 μg/mL, but only moderate activity against S. haemolyticus and S. aureus, with MIC values of 25 and 50 μg/mL, respectively. Usnic acid showed strong activity against resistant strains of S. epidermidis (MIC 3.12 μg/mL), S. aureus and S. haemolyticus (MIC 12.5 μg/mL), but moderate activity against E. faecalis (MIC 50 μg/mL). Difractaic acid was inactive when evaluated against the resistant strains (MIC values higher than 100 μg/mL).
Numerous lichen compounds were previously screened for antimicrobial activity in search of new antimicrobial agents [15] [16] [17] and the broad antimicrobial activity of (+)-usnic acid has been reported by several authors [18] [19] [20] . Weckesser et al. [3] reported that Usnea barbata extract and (+)-usnic acid inhibited the growth of aerobic Gram-positive strains like methicillin-resistant S. aureus.
Recently, Ranković et al. [21] investigated the chemical composition of the acetone extracts of the lichens Toninia candida and Usnea barbata and the in vitro antioxidant, antimicrobial, and anticancer activities of these extracts, together with some of their major metabolites. In this study, the authors reported that the most active was (+)-usnic acid, with minimum inhibitory concentrations ranging from 0.0008 to 0.5 mg/mL.
The results presented in this work demonstrate that (+)-usnic acid is a major secondary metabolite of U. steineri, and the strong antibacterial activity displayed by the acetone extract against S. epidermidis (6.25 μg/mL) might be justified by the presence of this compound. The activity against E. faecalis (6.25 μg/mL) of the acetone extract might be associated with a synergistic effect between (+)-usnic acid and difractaic acid because the MIC value showed by (+)-usnic acid alone was 50 μg/mL.
Several studies have reported the synergistic effect obtained by the association of products obtained from natural sources and antibiotics [22, 23] . The idea that any combination of antimicrobials could act synergistically is simplistic. Synergy is ideally defined as the interaction of two or more substances to produce a combined effect greater than the sum of their separate effects [24, 25] .
The results obtained in the synergistic antimicrobial test indicate that the combinations of penicillin and tetracycline with (+)-usnic acid did not show any synergistic properties when the checkerboard methodology described by White et al. [26] was used ( Table 2 ). According to this author, the fractional inhibitory concentration (FIC) index found for the strains of S. aureus (2.25), S. epidermidis (1.5) and E. faecalis (2.0) indicate "indifference", showing that the antimicrobial activity was not improved when the substances were associated. The obtained FIC index for S. haemolyticus (4.5) indicated "antagonism" because the antimicrobial activity was considerably reduced when the substances were associated. In 2012, Segatore et al. [25] evaluated the in vitro antimicrobial activities of (+)-usnic acid in combination with five therapeutically available antibiotics using a checkerboard microdilution assay against methicillin-resistant clinical isolates of Staphylococcus aureus. According to the fractional inhibitory concentration index (FICI) interpretation, synergism was found in this study only for S. aureus AQ004 in combination with clindamycin (FICI = 0.2813), for ATCC43300, AQ004 and AQ0012 (FICI = 0.375) in combination with gentamicin, and for ATCC43300 (FICI = 0.5) in combination with oxacillin.
Bacterial pathogens are becoming increasingly resistant to even the most recently approved antibiotics [27] . There is a crucial and urgent need for the development of new classes of antibiotics or for revitalizing the already used antibiotics. A small number of combinations are commercially available for the treatment of resistant infections [28] . This has stimulated investigation into the antimicrobial activity of different natural sources to promote the development of new drugs [29] .
Our results indicate the relevance of (+)-usnic acid in the search for new effective antimicrobial agents against multi-drug resistant pathogens. Although (+)-usnic acid is able to inhibit bacterial growth with very promising MIC values, further studies are necessary to ensure the safe use of this compound.
Experimental

General experimental procedures:
Optical rotations were measured on a Jasco, P-2000 model polarimeter. The NMR spectra were recorded on a Bruker ARX 400 spectrometer. The samples were dissolved in chloroform-d and methanol-d4. The analytical and semi-preparative HPLC analyses were performed on a Shimadzu LC-6AD system equipped with a degasser DGU-20A5, a UV-VIS detector SPD-20A series with a CBM-20A module, and a Reodyne manual injector. The analytical and semi-preparative separations were accomplished using Shimadzu Shim-pack ODS columns (250 × 4.6 mm and 250 × 20 mm, respectively) equipped with a precolumn of the same material. The mobile phase used for the chromatographic purification was acetonitrile/water (64:36) with 0.5% trifluoroacetic acid, UV detection: 254 nm. Preparation of the extract, isolation and identification of the compounds: U. steineri was dried in an oven with circulating air (40 ºC) and powdered using a knife mill. The obtained powder (300 g) was exhaustively extracted with acetone by maceration, which was followed by filtration. The filtered extract was concentrated under reduced pressure, yielding 18 g of extract. An aliquot of the extract was analyzed by HPLC and subjected to HPLC semipreparative purification, obtaining difractaic acid (1) 
Determination of the antimicrobial activity:
The minimum inhibitory concentration (MIC) values and the minimum bactericidal concentration (MBC) were determined in triplicate using the broth microdilution method in 96-well microplates [30] . The tested strains were isolated from clinical specimens. The samples were dissolved in DMSO (dimethyl sulfoxide), followed by dilution in tryptic soy broth, and concentrations ranging from 400.0 to 0.19 μg/mL were achieved. Vancomycin (Sigma-Aldrich) at concentrations varying from 0.01 to 5.9 μg/mL was used as the positive control. The inoculum was adjusted for each organism to yield a cell concentration of 5 x 10 5 colony forming units per mL, according to the guidelines of the Clinical Laboratory Standards Institute [31] . One inoculated well was included to allow for control of the adequacy of the broth for organism growth. One noninoculated well, which was free of the antimicrobial agent, was included to ensure medium sterility. The microplates (96 wells) were sealed with plastic film and incubated at 37°C for 24 h. Resazurin (25 μL) in aqueous solution (0.02%) was added to the microplates to indicate microorganism viability [32] . The MIC value was determined as the lowest concentration of the compound capable of inhibiting microorganism growth.
Before the addition of resazurin to determine the MBC (the lowest concentration of the compound at which 99.99% or more of the initial inoculum was killed), an aliquot of the inoculum was aseptically removed from each well that showed no apparent growth, and the inoculum was plated onto tryptic soy agar supplemented with 5% sheep blood. The plates were incubated as previously described.
Synergistic antimicrobial activity:
Checkerboard assays were performed according to the protocol previously described by White et al. [26] Synergy was defined as an FIC index of ≤0.5. Indifference was defined as an FIC index of >0.5 but ≤4. Antagonism was defined as an FIC index of >4 [26] .
